Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sekisui XenoTech

Sekisui XenoTech?uq=w9if130k
1994 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of healthcare research services. The company performs tests on non transplantable human livers to find out how drugs metabolized in humans.

Formerly Known As
Xenotech
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • 1101 West Cambridge Circle Drive
  • Kansas City, MO 66103
  • United States

+1 (877) 000-0000

Sekisui XenoTech Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sekisui XenoTech‘s full profile, request access.

Request full access to PitchBook

Sekisui XenoTech Executive Team (5)

Name Title Board
Seat
Contact
Info
Yasuhisa Adachi Ph.D Chief Executive Officer
Joe Saitta Chief Financial Officer
Jason Neat Chief Operating Officer
David Buckley Ph.D Chief Scientific Officer
Andrew Parkinson Founder